Goldberg B, Ackerman M
mBio. 2024; 16(1):e0190024.
PMID: 39660921
PMC: 11708040.
DOI: 10.1128/mbio.01900-24.
Ghofrani J, Bowen A, Chen J, Balakrishnan P, Powell A, Cherukula K
Int J Nanomedicine. 2023; 18:4055-4066.
PMID: 37520301
PMC: 10386837.
DOI: 10.2147/IJN.S401304.
Grunst M, Ladd R, Clark N, Gil H, Klenchin V, Mason R
PLoS Pathog. 2023; 19(5):e1011407.
PMID: 37253062
PMC: 10256149.
DOI: 10.1371/journal.ppat.1011407.
Kuriakose Gift S, Wieczorek L, Sanders-Buell E, Zemil M, Molnar S, Donofrio G
J Virol. 2023; 97(2):e0163522.
PMID: 36749076
PMC: 9973046.
DOI: 10.1128/jvi.01635-22.
Bernard N, Kant S, Kiani Z, Tremblay C, Dupuy F
Front Immunol. 2022; 13:879124.
PMID: 35720328
PMC: 9205404.
DOI: 10.3389/fimmu.2022.879124.
E4orf1 Suppresses -Deleted Adenovirus Vaccine-Induced Immune Responses.
Sangare K, Hait S, Moore M, Hogge C, Hoang T, Rahman M
Vaccines (Basel). 2022; 10(2).
PMID: 35214753
PMC: 8875587.
DOI: 10.3390/vaccines10020295.
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
Mielke D, Bandawe G, Zheng J, Jones J, Abrahams M, Bekker V
PLoS Pathog. 2021; 17(11):e1010046.
PMID: 34788337
PMC: 8598021.
DOI: 10.1371/journal.ppat.1010046.
Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
Mielke D, Stanfield-Oakley S, Borate B, Fisher L, Faircloth K, Tuyishime M
J Virol. 2021; 96(2):e0164321.
PMID: 34730393
PMC: 8791251.
DOI: 10.1128/JVI.01643-21.
Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features.
Cheng H, Dowell K, Bailey-Kellogg C, Goods B, Love J, Ferrari G
Retrovirology. 2021; 18(1):35.
PMID: 34717659
PMC: 8557579.
DOI: 10.1186/s12977-021-00579-9.
Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Ponnan S, Thiruvengadam K, Tellapragada C, Ambikan A, Narayanan A, Kathirvel S
Microbiol Spectr. 2021; 9(2):e0047021.
PMID: 34704803
PMC: 8549735.
DOI: 10.1128/Spectrum.00470-21.
Enhancement of Antibody-Dependent Cellular Cytotoxicity and Phagocytosis in Anti-HIV-1 Human-Bovine Chimeric Broadly Neutralizing Antibodies.
Edwards J, Heydarchi B, Khoury G, Salazar-Quiroz N, Gonelli C, Wines B
J Virol. 2021; 95(13):e0021921.
PMID: 33853957
PMC: 8316091.
DOI: 10.1128/JVI.00219-21.
Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features.
Bartsch Y, Loos C, Rossignol E, Fajnzylber J, Yuan D, Avihingsanon A
mBio. 2021; 12(2).
PMID: 33688003
PMC: 8092214.
DOI: 10.1128/mBio.00170-21.
Natural killer cell phenotype is altered in HIV-exposed seronegative women.
Zhao N, Vendrame E, Ferreira A, Seiler C, Ranganath T, Alary M
PLoS One. 2020; 15(9):e0238347.
PMID: 32870938
PMC: 7462289.
DOI: 10.1371/journal.pone.0238347.
Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection.
Ramadoss N, Zhao N, Richardson B, Grant P, Kim P, Blish C
AIDS. 2020; 34(9):1313-1323.
PMID: 32287071
PMC: 7595577.
DOI: 10.1097/QAD.0000000000002543.
Differential Effect of Mucosal NKp44 Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques.
Rahman M, Ko E, Enyindah-Asonye G, Hait S, Hogge C, Hunegnaw R
J Immunol. 2019; 203(9):2459-2471.
PMID: 31554692
PMC: 6810926.
DOI: 10.4049/jimmunol.1900572.
Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants.
Naiman N, Slyker J, Richardson B, John-Stewart G, Nduati R, Overbaugh J
EBioMedicine. 2019; 47:257-268.
PMID: 31501077
PMC: 6796543.
DOI: 10.1016/j.ebiom.2019.08.072.
Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections.
Anand S, Finzi A
Vaccines (Basel). 2019; 7(3).
PMID: 31480293
PMC: 6789852.
DOI: 10.3390/vaccines7030103.
Deficient IL-2 Produced by Activated CD56 T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection.
Xie Z, Zheng J, Wang Y, Li D, Maermaer T, Li Y
Front Immunol. 2019; 10:1647.
PMID: 31379845
PMC: 6648879.
DOI: 10.3389/fimmu.2019.01647.
Chronic HIV-1 Infection Alters the Cellular Distribution of FcγRIIIa and the Functional Consequence of the FcγRIIIa-F158V Variant.
Phaahla N, Lassauniere R, Dias B, Waja Z, Martinson N, Tiemessen C
Front Immunol. 2019; 10:735.
PMID: 31024562
PMC: 6467939.
DOI: 10.3389/fimmu.2019.00735.
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function.
Crowley A, Ackerman M
Front Immunol. 2019; 10:697.
PMID: 31024542
PMC: 6463756.
DOI: 10.3389/fimmu.2019.00697.